Radiotherapy Plus Hormone Therapy Boosts Prostate Cancer Outcomes

Combining radiotherapy-based, metastasis-directed therapy with hormone therapy led to better progression-free survival for patients with oligometastatic prostate cancer.

Related Keywords

Boston ,Massachusetts ,United States ,Houston ,Texas ,Chad ,Nima Aghdam ,Los Angeles ,Shankar Siva ,Stuart Burri ,Howardm Sandler ,American Society For Radiation Oncology ,Sinai Medical Center ,University Of Texas Md Anderson Cancer Center ,Twitter ,Beth Israel Deaconess Medical Center ,Oschin Cancer Institute ,Chad Tang ,Cancer Center ,American Society ,Radiation Oncology ,Annual Meeting ,Medscape Medical News ,Cedars Sinai Medical Center ,Prostate Carcinoma ,Alignant Prostate Neoplasm ,Prostate Cancer ,Ancer Prostate ,Endocrine Therapy ,Hormone Therapy ,Goal Directed Therapy ,Adt ,Arly Goal Directed Therapy ,Gdt ,Atient Goal Directed Therapy ,Metastasis ,Cancer ,Alignant Neoplasia ,Arcinoma ,Metastatic And Advanced Prostate Cancer ,Prostate Specific Antigen Psa ,Rostate Specific Antige ,